{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:48:03Z","timestamp":1791946083602,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH1610751"],"award-info":[{"award-number":["W81XWH1610751"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2010733"],"award-info":[{"award-number":["W81XWH2010733"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR066053"],"award-info":[{"award-number":["R01 AR066053"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR073761"],"award-info":[{"award-number":["P30 AR073761"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jbc.2025.110470","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:00:28Z","timestamp":1752570028000},"page":"110470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modulation of the PTPRS proteoglycan switch by antibodies binding to the membrane-proximal fibronectin-type III domain"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-0471","authenticated-orcid":false,"given":"Thales","family":"Hein Da Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling H.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Y.","family":"Kozlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9392-1492","authenticated-orcid":false,"given":"Zixuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3457-5190","authenticated-orcid":false,"given":"Jaeyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6327-3793","authenticated-orcid":false,"given":"Ava C.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4092-9386","authenticated-orcid":false,"given":"Madhusudhanarao","family":"Katiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Firestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8384-2793","authenticated-orcid":false,"given":"Ramachandran","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-2750","authenticated-orcid":false,"given":"Eugenio","family":"Santelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9025-7501","authenticated-orcid":false,"given":"Nunzio","family":"Bottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110470_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ceb.2009.01.028","article-title":"Tyrosine phosphorylation: thirty years and counting","volume":"21","author":"Hunter","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110470_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jbc.2025.110470_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jbc.2025.110470_bib4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/aps.2014.80","article-title":"Protein tyrosine phosphatases as potential therapeutic targets","volume":"35","author":"He","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jbc.2025.110470_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113990","article-title":"Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: update","volume":"157","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbc.2025.110470_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41586-023-06575-7","article-title":"The PTPN2\/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity","volume":"622","author":"Baumgartner","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110470_bib7","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/2159-8290.CD-23-0361","article-title":"SHP2 inhibition sensitizes diverse oncogene-addicted solid tumors to Re-treatment with targeted therapy","volume":"13","author":"Drilon","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2025.110470_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cac2.12548","article-title":"Protein tyrosine phosphatases: emerging role in cancer therapy resistance","volume":"44","author":"Zhao","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jbc.2025.110470_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116031","article-title":"Targeting phosphatases: from molecule design to clinical trials","volume":"264","author":"Guo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2025.110470_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110470_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1742-4658.2008.06247.x","article-title":"Protein tyrosine phosphatases: regulatory mechanisms","volume":"275","author":"den Hertog","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2025.110470_bib12","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2017.03.004","article-title":"Targeting tyrosine phosphatases: time to end the stigma","volume":"38","author":"Stanford","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2025.110470_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1101\/gad.350713.123","article-title":"Manipulating PTPRD function with ectodomain antibodies","volume":"37","author":"Qian","year":"2023","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2025.110470_bib14","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2025.110470_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors","volume":"9","author":"Bottini","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jbc.2025.110470_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102304","article-title":"Targeting fibroblast-like synoviocytes in rheumatoid arthritis","volume":"67","author":"Tsaltskan","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110470_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4616","article-title":"Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy","volume":"7","author":"Doody","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2025.110470_bib18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.1200840","article-title":"Proteoglycan-specific molecular switch for RPTP\u03c3 clustering and neuronal extension","volume":"332","author":"Coles","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.110470_bib19","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1038\/ncomms6209","article-title":"Structural basis for extracellular cis and transRPTP\u03c3 signal competition in synaptogenesis","volume":"5","author":"Coles","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110470_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41467-019-13949-x","article-title":"Structural basis of liprin-\u03b1-promoted LAR-RPTP clustering for modulation of phosphatase activity","volume":"11","author":"Xie","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110470_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba4353","article-title":"Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal","volume":"6","author":"Svensson","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2025.110470_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcdb.2014.09.007","article-title":"Extracellular regulation of type IIa receptor protein tyrosine phosphatases: mechanistic insights from structural analyses","volume":"37","author":"Coles","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2025.110470_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.immuni.2015.07.009","article-title":"Protein tyrosine phosphatase PTPRS is an inhibitory receptor on human and murine plasmacytoid dendritic cells","volume":"43","author":"Bunin","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2025.110470_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcdb.2014.09.006","article-title":"RPTPs in axons, synapses and neurology","volume":"37","author":"Stoker","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2025.110470_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4161\/cam.21242","article-title":"Receptor protein tyrosine phosphatases and cancer","volume":"6","author":"Nikolaienko","year":"2012","journal-title":"Cell Adhes. Migration"},{"key":"10.1016\/j.jbc.2025.110470_bib26","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1523\/JNEUROSCI.23-08-03353.2003","article-title":"Leukocyte antigen-related protein tyrosine phosphatase receptor: a small ectodomain isoform functions as a homophilic ligand and promotes neurite outgrowth","volume":"23","author":"Yang","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbc.2025.110470_bib27","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1460-9568.2005.04403.x","article-title":"Identification of an ectodomain within the LAR protein tyrosine phosphatase receptor that binds homophilically and activates signalling pathways promoting neurite outgrowth","volume":"22","author":"Yang","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jbc.2025.110470_bib28","doi-asserted-by":"crossref","first-page":"11639","DOI":"10.1074\/jbc.RA118.003081","article-title":"Identification of novel binding sites for heparin in RPTP\u03c3: implications for proteoglycan signaling","volume":"293","author":"Katagiri","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110470_bib29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1178310","article-title":"PTP\u03c3 is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration","volume":"326","author":"Shen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.110470_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110470_bib31","doi-asserted-by":"crossref","first-page":"15.22.1","DOI":"10.1002\/0471142735.im1522s81","article-title":"The K\/BxN arthritis model","volume":"81","author":"Monach","year":"2008","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.jbc.2025.110470_bib32","doi-asserted-by":"crossref","first-page":"vi12","DOI":"10.1093\/rheumatology\/keab609","article-title":"Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs","volume":"60","author":"Tanaka","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbc.2025.110470_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002387","article-title":"\u201cDifficult to treat\u201d rheumatoid arthritis: current position and considerations for next steps","volume":"8","author":"Tan","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.jbc.2025.110470_bib34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13287-023-03473-7","article-title":"Rheumatoid arthritis: the old issue, the new therapeutic approach","volume":"14","author":"Babaahmadi","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jbc.2025.110470_bib35","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/annrheumdis-2021-222021","article-title":"Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?","volume":"81","author":"N\u00e9meth","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbc.2025.110470_bib36","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1073\/pnas.1200024109","article-title":"Isotype modulates epitope specificity, affinity, and antiviral activities of anti\u2013HIV-1 human broadly neutralizing 2F5 antibody","volume":"109","author":"Tudor","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110470_bib37","doi-asserted-by":"crossref","first-page":"12272","DOI":"10.1073\/pnas.1209750109","article-title":"Immunoglobulin isotype influences affinity and specificity","volume":"109","author":"Casadevall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110470_bib38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/6859","article-title":"Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase \u03c3","volume":"21","author":"Elchebly","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2025.110470_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbc.2025.110470_bib40","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2020-219247","article-title":"\u2018SMASH\u2019 recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models","volume":"80","author":"Hayer","year":"2021","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825023208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825023208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:46:40Z","timestamp":1777459600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825023208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0021925825023208"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110470","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of the PTPRS proteoglycan switch by antibodies binding to the membrane-proximal fibronectin-type III domain","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110470"}}